Summary
The acute renal effects of a single oral dose of felodipine 0.15 mg/kg were studied in 8 healthy males. Thirty minutes after administration the mean plasma concentration was 25.7 nmol/l. There was a significant reduction in diastolic blood pressure (24%) and a concomitant rise in heart rate (38%), leaving the systolic pressure unchanged. Glomerular filtration rate (GFR) and renal plasma flow (RPF) were measured by the constant infusion technique using the clearance of125I-iothalamate and131I-hippuran respectively. GFR was unchanged and the filtration fraction (FF) was reduced, whilst there was a decrease in renal vascular resistance (RVR). The glomerular filter characteristics were unchanged, as estimated by the unchanged excretion rate of albumin. There was a significant rise in the clearance of sodium (176%) but only a small and insignificant increase in urine volume. Clearance of potassium was decreased. An increase in the clearance of uric acid and a rise in the beta-2-microglobulin excretion rate were found, both suggesting a proximal tubular effect of felodipine. The excretion rate of calcium was increased.
Similar content being viewed by others
References
Elmfeldt D, Hedner T (1983) Felodipine — A new vasodilator, in addition to beta-receptor blockade in hypertension. Eur J Clin Pharmacol 25: 571–575
Co-Operative Study Group (1987) Felodipine versus hydralazine: A controlled trial as third line therapy in hypertension. Br J Clin Pharmacol (in press)
Johnsson G, Murray G, Tweddel A, Hutton I (1983) Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects. Eur J Clin Pharmacol 24: 49–53
Andersson OK, Granérus G, Hedner T, Wysocki M (1985) Systemic and renal hemodynamic effects of single oral doses of felodipine in patients with refractory hypertension receiving chronic therapy with beta-blockers and diuretics. J Cardiovasc Pharmacol 7: 544–549
Ljung B (1985) Vascular selectivity of felodipine. Drugs 29 [Suppl 2]: 46–58
Leonetti G, Fruscio M, Terzoli L, Rupoli L, Gradnik R, Sampieri L, Cuspidi C, Boselli L, Bolla G, Zanchetti A (1985) Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist, in hypertensive patients. Drugs 29 [Suppl 2]: 185–191
Edgar B, Bengtsson B, Elmfeldt D, Lundborg P, Nyberg G, Raner S, Rönn O (1985) Acute diuretic/natriuretic properties of felodipine in man. Drugs 29 [Suppl 2]: 176–184
Sluiter HE, Huysmans FTM, Thien TA, van Lier HJJ, Koene RAP (1985) Haemodynamic, hormonal, and diuretic effects of felodipine in healthy normotensive volunteers. Drugs 29 [Suppl 2]: 26–35
Dibona GF, Sawin LL (1984) Renal tubular site of action of felodipine. J Pharmacol Exp Ther 228: 420–424
Herlitz H, Aurell M, Björck S, Granérus G (1985) Renal effects of felodipine in hypertensive patients with reduced renal function. Drugs 29 [Suppl 2]: 192–197
Christensen CK, Lederballe-Pedersen O, Mikkelsen E (1982) Renal effects of acute calcium blockade with nifedipine in hypertensive patients receiving beta-adrenoceptor-blocking drugs. Clin Pharmacol Ther 32: 572–576
Mogensen CE (1971) Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest 28: 91–97
Miles DW, Mogensen CE, Gundersen HJG (1970) Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest 26: 5–11
Ahnoff M (1984) Determination of felodipine in plasma by gas chromatography with electron capture detection. J Pharmacol Biomed Anal 2: 519–526
Windhager EE, Taylor A (1983) Regulatory role of intracellular calcium ions in epithelial Na transport. Ann Rev Physiol 45: 519–532
Gross F (1977) Drugs acting on arteriolar smooth muscle (vasodilator drugs). In: Gross F (ed) Antihypertensive agents. Springer, Berlin Heidelberg New York, pp 397–476
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmitz, A. Acute renal effects of oral felodipine in normal man. Eur J Clin Pharmacol 32, 17–22 (1987). https://doi.org/10.1007/BF00609952
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609952